Glucagon-like peptide-1
US$ 20.34
glp-1 receptor GLP-1R and Diabetes Frontiers | GLP−1 receptor agonists
Description
Interaction risk
They do this by mimicking glucagon-like peptide-1 (GLP-1), a hormone made naturally in the human gut
The move greatly broadens access for existing players like Lilly and Novo, but could cool incentives for new competitors and push back obesity drug innovation
In participants who received albiglutide, HbA1c and fasting blood glucose levels were significantly reduced compared with those in sitagliptin-treated participants
